Redefining MTM in the Post-health Reform Era
The healthcare industry has hit a crossroads that requires a strategic choice regarding the most effective allocation and use of clinical pharmacy resources on the path to performance improvement. As value-based care models drive the need for greater collaboration across clinical settings, the critical role of pharmacy expertise is heightened to accommodate a greater focus on ensuring medication effectiveness and minimizing potential for medication-related harm — a national crisis that has become the focal point of the risk-bearing regulatory landscape.
You may also like:
It may not be exciting or cutting-edge, but the pharmaceutical supply chain and pharmacy profession’s operations are tied to an infrastructure that depends on a 10- or 11-digit number: the
A recent study found the use of non-steroidal anti-inflammatory drugs (NSAIDs) in combination with oral anticoagulant therapy in patients with atrial fibrillation was associated with an increased risk of major bleeding compared...
Last week, the U.S. Senate passed its ambitious Opioid Crisis Response Act of 2018 (S.2680) by a vote of 99 to 1. The bill differs...
Stay in the Know
Sign up to start receiving notifications via email of our upcoming webinars!